Skip to main content
Log in

DXA-based bone strain index in normocalcemic primary hyperparathyroidism

  • Short Communication
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The trabecular and cortical bone assessed by bone strain index seems not to be significantly affected in NHPT.

Introduction

The natural history and bone involvement of normocalcemic hyperparathyroidism (NHPT) are not fully clarified yet. The bone strain index (BSI) is a deformation index based on the finite element method and can be applied to DXA scans. In this study, we aim to assess BSI in subjects with NHPT.

Method

A case–control study included 170 subjects: 40 subjects with NHPT, 50 subjects with primary hypercalcemic hyperparathyroidism (PHPT), and 80 controls (age- and sex-matched with the NPTH group).

Results

Lumbar spine (LS) bone mineral density (BMD), femoral neck (FN) BMD, total hip (TH) BMD, and TBS were similar between NHPT and both PHPT and controls. FN-BSI was lower in NHPT compared to PHPT (1.52 ± 0.31 vs 1.72 ± 0.42 p = 0.031) while there were no differences between NHPT and controls. TH-BSI was lower in NHPT compared to PHPT (1.36 ± 0.23 vs 1.52 ± 0.34, p = 0.030), while there were no differences between NHPT and controls. LS-BSI was not different between NHPT and both PHPT and controls.

Conclusion

The trabecular and cortical bones assessed by BSI seem not to be significantly impaired in NHPT. Further prospective studies are needed to confirm these findings and to give an insight into the natural history of NHPT to improve knowledge and management of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data Availability

The data that support the findings of this study are available from the corresponding author (GT), upon reasonable request.

References:

  1. Eastell R, Brandi ML, Costa AG, D’Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10):3570–3579

    Article  CAS  PubMed  Google Scholar 

  2. Schini M, Jacques RM, Oakes E, Peel NFA, Walsh JS, Eastell R (2020) Normocalcemic hyperparathyroidism: study of its prevalence and natural history. J Clin Endocrinol Metab 105(4):e1171–e1186

    Article  PubMed  PubMed Central  Google Scholar 

  3. Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D et al (2020) Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 105(7):dgaa174. https://doi.org/10.1210/clinem/dgaa174

  4. Naciu AM, Tabacco G, Falcone S, Incognito GG, Chiodini I, Maggi D et al (2021) Bone quality as measured by trabecular bone score in normocalcemic primary hyperparathyroidism. Endocr Pract 27(10):992–997

    Article  PubMed  Google Scholar 

  5. Tecnologie Avanzate - Bone Strain Index. https://www.tecnologie-avanzate.com/ricerca-e-sviluppo/bone-strain-index. Accessed 12 Jan 2023

  6. Ulivieri FM, Rinaudo L (2021) Beyond bone mineral density: a new dual X-ray absorptiometry index of bone strength to predict fragility fractures, the bone strain index. Front Med (Lausanne) 7:590139. https://doi.org/10.3389/fmed.2020.590139

  7. Ulivieri FM, Rebagliati GAA, Piodi LP, Solimeno LP, Pasta G, Boccalandro E et al (2018) Usefulness of bone microarchitectural and geometric DXA-derived parameters in haemophilic patients. Haemophilia 24(6):980–987

    Article  CAS  PubMed  Google Scholar 

  8. Rodari G, Scuvera G, Ulivieri FM, Profka E, Menni F, Saletti V et al (2018) Progressive bone impairment with age and pubertal development in neurofibromatosis type I. Arch Osteoporos 13(1):93

    Article  PubMed  Google Scholar 

  9. Ulivieri FM, Piodi LP, Grossi E, Rinaudo L, Messina C, Tassi AP et al (2018) The role of carboxy-terminal cross-linking telopeptide of type I collagen, dual x-ray absorptiometry bone strain and Romberg test in a new osteoporotic fracture risk evaluation: a proposal from an observational study. Chung CK, ed. PLoS ONE 13(1):e0190477

    Article  PubMed  PubMed Central  Google Scholar 

  10. Messina C, Rinaudo L, Cesana BM, Maresca D, Piodi LP, Sconfienza LM et al (2020) Prediction of osteoporotic fragility re-fracture with lumbar spine DXA-based derived bone strain index: a multicenter validation study. Osteoporos Int 32(1):85–91. https://doi.org/10.1007/s00198-020-05620-9

  11. Tabacco G, Naciu AM, Messina C, Sanson G, Rinaudo L, Cesareo R et al (2021) DXA-based bone strain index: a new tool to evaluate bone quality in primary hyperparathyroidism. J Clin Endocrinol Metab 106(8):2304–2312

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zavatta G, Clarke BL (2021) Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach. Endocrinol Metab (Seoul, Korea) 36(3):525–535

    Article  CAS  Google Scholar 

  13. Rejnmark L, Ejlsmark-Svensson H (2020) Effects of PTH and PTH hypersecretion on bone: a clinical perspective. Curr Osteoporos Reports 18(3):103–114

    Article  Google Scholar 

  14. Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM et al (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98(7):2734–2741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):351–365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88(10):4641–4648

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study design: GT, AMN, and AP; data collection: GT, AMN, GS, SF, and AP; data analysis: GT, AMN, CM, GS, LR, and AP; data interpretation: GT, AMN, CM, GS, LR, RC, FMU, and AP; drafting manuscript: GT, AMN, GS, FMU, and AP; revising manuscript content: GT, AMN, CM, LR, GS, RC, SF, NN, FMU, and AP; approving the final version of manuscript: GT, AMN, CM, LR, GS, RC, SF, NN, FMU, and AP. All authors take responsibility for the integrity of the data analysis.

Corresponding author

Correspondence to Gaia Tabacco.

Ethics declarations

Conflict of interest

C. Messina, G. Sanson, S. Falcone, and F.M. Ulivieri disclosed no conflict of interest; G Tabacco disclosed lecture fees from Amgen; L. Rinaudo was put in charge of the BSI project by Tecnologie Avanzate s.r.l.; A.M. Naciu and R. Cesareo disclosed lecture fees from Amgen and Bruno Farmaceutici; N. Napoli disclosed consultant for Lilly, Abiogen, and UCB; A. Palermo disclosed lecture fees from Amgen and Abiogen.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabacco, G., Naciu, A.M., Messina, C. et al. DXA-based bone strain index in normocalcemic primary hyperparathyroidism. Osteoporos Int 34, 999–1003 (2023). https://doi.org/10.1007/s00198-023-06669-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-023-06669-y

Keywords

Navigation